SCHEMBL9537279

SCHEMBL9537279

CCC(=O)N1Cc2cnn(C)c2-c2cc(Cl)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 1/20 0.43
▸ HTT P42858 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HSD17B3 P37058 5/20 0.38
▸ GABRG2 P18507 3/20 0.37
▸ GABRB3 P28472 3/20 0.37
▸ GABRA5 P31644 3/20 0.37
▸ HTR2A P28223 3/20 0.37
▸ HTR2C P28335 3/20 0.37
▸ TSHR P16473 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CYP11B1 P15538 2/20 0.36
▸ CYP11B2 P19099 2/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ GABRA1 P14867 2/20 0.35
▸ GABRA3 P34903 2/20 0.35
▸ GABRA2 P47869 2/20 0.35
▸ GABRA6 Q16445 2/20 0.35
▸ GABRB2 P47870 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9538692 0.87 ADORA3 (0.42) ADORA3HTTKDM4ESMN1; SMN2HSD17B3
SCHEMBL9538271 0.87 ADORA3 (0.40) ADORA3HTTKDM4ESMN1; SMN2HSD17B3
SCHEMBL9535647 0.86 ADORA3 (0.45) ADORA3GABRG2GABRB3GABRA5HTR2A
SCHEMBL9537919 0.86 AVPR1A (0.40) KDM4EHSD17B3HTR2AHTR2CBRD4
SCHEMBL9536781 0.86 KDM4E (0.39) ADORA3HTTKDM4ESMN1; SMN2HSD17B3
SCHEMBL9540686 0.86 HTR2A (0.37) KDM4EHSD17B3GABRG2GABRB3GABRA5
SCHEMBL9535510 0.85 BRD4 (0.37) HSD17B3GABRG2GABRB3GABRA5HTR2A
SCHEMBL9537519 0.85 ADORA3 (0.41) ADORA3HTTKDM4ESMN1; SMN2HSD17B3
SCHEMBL9540537 0.84 ADORA3 (0.42) ADORA3HTTKDM4ESMN1; SMN2HSD17B3
SCHEMBL9537679 0.84 ADORA3 (0.39) ADORA3HTTKDM4ESMN1; SMN2HSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0180352-B1 BENZENE-FUSED HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-05-26 — — EP claimed
US-4675324-A Substituted pyrazolo [4,3-c]pyridines and their use as uricosuric, diuretic and anti-hypertensive agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-06-23 — — US claimed
EP-0180352-A2 Benzene-fused heterocyclic compound FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 — — EP claimed
JP-61112076-A — — None — — JP disclosed
EP-0180352-B1 BENZENE-FUSED HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-05-26 — — EP disclosed
US-4767780-A SUBSTITUTED 1,4-DIHYDRO-(1)-BENZOPYRANO(4,3-C)PYRAZOLES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-08-30 — — US disclosed
US-4675324-A Substituted pyrazolo [4,3-c]pyridines and their use as uricosuric, diuretic and anti-hypertensive agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-06-23 — — US disclosed
JP-S61112076-A BENZENE-CONDENSED HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUT CO LTD 1986-05-30 — — JP disclosed
EP-0180352-A2 Benzene-fused heterocyclic compound FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 — — EP disclosed
Send feedback